Impact of basal inferolateral scar burden determined by automatic analysis of 99mTc-MIBI myocardial perfusion SPECT on the long-term prognosis of cardiac resynchronization therapy

Europace. 2017 Apr 1;19(4):573-580. doi: 10.1093/europace/euw068.

Abstract

Aims: Left-ventricular (LV) scarring may be associated with a poor response to cardiac resynchronization therapy (CRT). The automatic analysis of myocardial perfusion single-photon emission computed tomography (MP-SPECT) may provide objective quantification of LV scarring. We investigated the impact of LV scarring determined by an automatic analysis of MP-SPECT on short-term LV volume response as well as long-term outcome.

Methods and results: We studied consecutive 51 patients who were eligible to undergo 99mTc-MIBI MP-SPECT both at baseline and 6 months after CRT (ischaemic cardiomyopathies 31%). Quantitative perfusion SPECT was used to evaluate the defect extent (an index of global scarring) and the LV 17-segment regional uptake ratio (an inverse index of regional scar burden). The primary outcome was the composite of overall mortality or first hospitalization for worsening heart failure. A high global scar burden and a low mid/basal inferolateral regional uptake ratio were associated with volume non-responders to CRT at 6 months. The basal inferolateral regional uptake ratio remained as a predictor of volume non-response after adjusting for the type of cardiomyopathy. During a median follow-up of 36.1 months, the outcome occurred in 28 patients. The patients with a low basal inferolateral regional uptake ratio with a cutoff value of 57% showed poor prognosis (log-rank P= 0.006).

Conclusion: The scarring determined by automatic analysis of MP-SPECT images may predict a poor response to CRT regardless of the pathogenesis of cardiomyopathy. The basal inferolateral scar burden in particular may have an adverse impact on long-term prognosis.

Keywords: Cardiac resynchronization therapy; Defect extent; Inferolateral scar; Non-responder; Quantitative perfusion SPECT; Regional uptake ratio.

MeSH terms

  • Aged
  • Cardiac Resynchronization Therapy / mortality*
  • Cardiac Resynchronization Therapy / statistics & numerical data
  • Causality
  • Comorbidity
  • Female
  • Heart Failure / diagnostic imaging
  • Heart Failure / mortality*
  • Heart Failure / prevention & control*
  • Humans
  • Japan / epidemiology
  • Longitudinal Studies
  • Male
  • Myocardial Perfusion Imaging / methods
  • Myocardial Perfusion Imaging / statistics & numerical data
  • Myocardial Stunning / diagnostic imaging
  • Myocardial Stunning / mortality
  • Myocardial Stunning / prevention & control
  • Prevalence
  • Prognosis
  • Radiopharmaceuticals
  • Reproducibility of Results
  • Retrospective Studies
  • Sensitivity and Specificity
  • Survival Analysis
  • Technetium Tc 99m Sestamibi*
  • Tomography, Emission-Computed, Single-Photon / methods
  • Tomography, Emission-Computed, Single-Photon / statistics & numerical data*
  • Treatment Outcome
  • Ventricular Dysfunction, Left / diagnostic imaging*
  • Ventricular Dysfunction, Left / mortality*
  • Ventricular Dysfunction, Left / prevention & control

Substances

  • Radiopharmaceuticals
  • Technetium Tc 99m Sestamibi